PPAR Inhibitors

PPARα

PPARβ/δ

PPARγ

PPAR

PPARδ

PPAR Inducers, Ligands, Inhibitors, Agonists, Antagonists, Activators & Modulators

Product Name	PPARα	PPARβ/δ	PPARγ	PPAR	PPARδ	Purity
Retinoic acid	PPARα, Kd: 103 nM PPARα, IC₅₀: 14 nM	PPARβ/δ, Kd: 17 nM RARβ, IC₅₀: 14 nM	PPARγ, Kd: 178 nM PPARγ, IC₅₀: 14 nM			99.81%
Rosiglitazone			PPARγ, Kd: 40 nM PPARγ, EC₅₀: 60 nM			99.94%
GW9662	PPARα, IC₅₀: 32 nM	PPARδ, IC₅₀: 2000 nM	PPARγ, IC₅₀: 3.3 nM			99.79%
Pioglitazone	hPPARα, EC₅₀: 100 μM mouse PPARα, EC₅₀: 100 μM	hPPARδ, EC₅₀: 43 μM	hPPARγ, EC₅₀: 0.93 μM mouse PPARγ, EC₅₀: 0.99 μM			99.89%
Fenofibrate	PPARα, IC₅₀: 30 μM					99.93%
1,1'-(Azodicarbonyl)-dipiperidine	PPARα		PPAR-γ		PPARδ
PPARγ agonist 14			PPARγ, EC₅₀: 2.4 μM
GW6471	PPARα					99.64%
5-Aminosalicylic Acid			PPARγ			99.82%
Pirinixic acid	PPARα, EC₅₀: 0.63 μM		PPARγ, EC₅₀: 32 μM			99.80%
Troglitazone			PPARγ, EC₅₀: 550 nM (Human PPARγ)			99.78%
T0070907	PPARα, Ki: 0.85 μM	PPARδ, Ki: 1.8 μM	PPARγ, Ki: 1 nM			99.98%
Astaxanthin			PPARγ			≥98.0%
Daidzein	PPAR-α		PPAR-γ			99.72%
Icariin	PPARα					99.06%
GW7647	PPARα, EC₅₀: 6 nM (Human PPARα)	PPARδ, EC₅₀: 6.2 μM (Human PPARδ)	PPARγ, EC₅₀: 1.1 μM (Human PPARγ)			99.45%
GW 501516		PPARδ, EC₅₀: 1.1 nM				99.43%
Elafibranor	PPAR-α, EC₅₀: 45 nM	PPAR-δ, EC₅₀: 175 nM				99.32%
GW1929			PPAR-γ, pEC₅₀: 8.56 (Human PPAR-γ)			99.93%
Glabridin			PPARγ, EC₅₀: 6.1 μM			99.98%
Oleuropein			PPARγ			99.05%
Bezafibrate	hPPARα, EC₅₀: 50 μM	hPPARδ, EC₅₀: 20 μM	hPPARγ, EC₅₀: 60 μM			99.83%
Anandamide				PPAR		≥99.0%
Pioglitazone hydrochloride	PPARα, EC₅₀: 0.93 μM (Human PPARα)	PPARδ, EC₅₀: 0.01 μM (Human PPARδ)	PPARγ, EC₅₀: 43 μM (Human PPARγ)			99.97%
Fucoxanthin	PPARα		PPARγ			98.99%
GW0742	PPARα, EC₅₀: 1.1 μM	PPARδ, EC₅₀: 1 nM	PPARγ, EC₅₀: 2 μM			99.94%
Magnolol			PPARγ, EC₅₀: 17.7 μM			99.84%
Oleoylethanolamide	PPAR-α					99.94%
Palacaparib				PPAR		99.11%
GSK3787		PPARδ, pIC₅₀: 6.6 nM				98.03%
FH535				PPAR		98.72%
Gemfibrozil	PPAR-α					99.91%
GSK0660		PPARβ/δ, IC₅₀: 155 nM				99.19%
1-Methyladenosine			PPAR-γ			99.21%
Rosiglitazone maleate			PPARγ1, EC₅₀: 30 nM PPARγ2, EC₅₀: 100 nM			99.88%
CDDO-Im	PPARα, Ki: 232 nM		PPARγ, Ki: 344 nM			98.47%
Palmitelaidic Acid	PPARα					≥99.0%
Pemafibrate	h-PPARα, EC₅₀: 1 nM	PPARδ, EC₅₀: 1.58 μM	h-PPARγ, EC₅₀: 1.1 μM			99.85%
Candesartan			PPAR-γ			98.03%
1,2-DLPC	PPARα					≥98.0%
Retinoic acid (Standard)	PPARα	PPARβ/δ RARβ	PPARγ
Eupatilin	PPARα					98.90%
FX-909			PPARγ			98.80%
Chiglitazar	PPARα, EC₅₀: 1.8 μM	PPARδ, EC₅₀: 1.7 μM	PPARγ, EC₅₀: 0.08 μM			98.81%
Fenofibric acid	PPARα, EC₅₀: 22.4 μM	PPARδ, EC₅₀: 1.06 μM	PPARγ, EC₅₀: 1.47 μM			99.94%
Bavachinin	PPARα, IC₅₀: 21.043 μM	PPARδ, IC₅₀: 12.819 μM	PPAR-γ, IC₅₀: 0.622 μM			99.95%
Alpinetin			PPAR-γ			99.51%
Seladelpar	PPAR-α, EC₅₀: 1600 nM	PPAR-δ, EC₅₀: 2 nM				99.75%
15-Deoxy-Δ-12,14-prostaglandin J2			PPARγ, EC₅₀: 2 μM			≥99.0%
Fmoc-leucine			PPARγ			99.91%
Seladelpar sodium salt		PPAR-δ, EC₅₀: 2 nM				98.77%
Rosiglitazone hydrochloride			PPARγ, EC₅₀: 60 nM PPARγ, Kd: 40 nM			99.31%
SR1664			PPAR-γ, IC₅₀: 80 nM			≥98.0%
Clofibrate	PPARα, EC₅₀: 50 μM		PPARγ, EC₅₀: 500 μM			99.61%
Saroglitazar	PPARα, EC₅₀: 0.65 pM (HepG2 cell)		PPARγ, EC₅₀: 3 nM (HepG2 cell)			99.10%
Agrimol B			PPARγ			99.75%
Bilobetin	PPARα					99.39%
Ophiopogonin D	PPARα					99.54%
Avicularin			PPARγ			99.80%
Ginsenoside Rh1			PPAR-γ			≥98.0%
Norathyriol	PPARα, IC₅₀: 92.8 μM	PPARβ, IC₅₀: 102.4 μM	PPARγ, IC₅₀: 153.5 μM			99.83%
Cefminox sodium			PPARγ			99.83%
Oroxin A			PPARγ			99.76%
4-O-Methyl honokiol			PPARγ			98.18%
Ertiprotafib	PPARα, EC₅₀: ~1 μM	PPARβ, EC₅₀: ~1 μM				98.86%
DG172 dihydrochloride		PPARβ/δ, IC₅₀: 27 nM				99.35%
NXT629	hPPARα, IC₅₀: 77 nM	hPPARδ, IC₅₀: 6 μM	hPPARγ, IC₅₀: 15 μM			99.07%
Mifobate			PPARγ, IC₅₀: 140 μM			99.10%
Hexadecanamide	PPARα
Ciprofibrate	PPARα					99.93%
PPARα/γ agonist 1	PPARα, EC₅₀: 28 nM		PPARγ, EC₅₀: 69 nM			99.68%
MTX-531			PPARγ, EC₅₀: 3.4 μM			99.87%
BMS-687453	PPARα, IC₅₀: 260 nM (Human PPARα)					99.31%
Licarin B			PPARγ			99.93%
BAY-4931			PPAR-γ, IC₅₀: 0.17 nM (RT112-FABP4-NLucP cellular reporter assay) mouse PPARγ, IC₅₀: 0.14 nM (GAL4-NHR-LBD one hybrid reporter assay ) hPPARγ, IC₅₀: 0.40 nM (GAL4-NHR-LBD one hybrid reporter assay )			98.83%
Glabrone			PPAR-γ			99.08%
Leriglitazone hydrochloride			PPAR-γ, EC₅₀: 9 μM			99.64%
AMG131			PPARγ			99.64%
Raspberry ketone	PPAR-α					99.91%
Gypenoside XLIX	PPAR-α					99.15%
L-165041		PPARδ, Ki: 6 nM	PPARγ, Ki: 730 nM			99.67%
GSK1820795A			hPPARγ, EC₅₀: 0.25 μM mouse PPARγ, EC₅₀: 0.27 μM			99.76%
PPARγ-IN-2			PPARγ			99.57%
Saroglitazar magnesium	PPARα, EC₅₀: 0.65 pM (HepG2 cell)		PPARγ, EC₅₀: 3 nM (HepG2 cell)			98.85%
Darglitazone			PPAR-γ			99.19%
Balaglitazone			PPARγ, EC₅₀: 351 nM (Human PPARγ)			99.74%
Etrinabdione			PPARγ			99.16%
Indeglitazar	PPARα	PPARδ	PPARγ			99.11%
HWL-088		PPARδ, EC₅₀: 570.9 nM				98.61%
BAY-0069			hPPARγ, IC₅₀: 6.3 nM mouse PPARγ, IC₅₀: 24 nM			98.07%
Daidzein (Standard)	PPAR-α		PPAR-γ			99.46%
Leriglitazone			PPAR-γ, EC₅₀: 9 μM			99.23%
CUDA	PPARα					≥98.0%
SR 16832			PPARγ			99.89%
GW 9578	mouse PPARα, EC₅₀: 5 nM h-PPARα, EC₅₀: 50 nM					99.6%
(10E,12Z)-Octadeca-10,12-dienoic acid	PPARα					99.10%
Drupanin	PPARα, EC₅₀: 39.0 μM		PPARγ, EC₅₀: 14.6 μM			98.05%
LT175	hPPARα, EC₅₀: 0.22 μM mPPARα, EC₅₀: 0.26 μM		hPPARγ, EC₅₀: 0.48 μM			99.79%
Aleglitazar	PPARα, IC₅₀: 38 nM		PPARγ, IC₅₀: 19 nM			99.74%
Adelmidrol			PPARγ			≥98.0%
FTX-6746			PPARγ			98.68%
Inolitazone dihydrochloride			PPARγ			98.86%
Falcarindiol			PPARγ			99.48%
CP-868388 free base	hPPARα, Ki: 10.8 nM		hPPARγ, Ki: 3.47 μM			99.66%
Lobeglitazone	PPARα, EC₅₀: 546.3 nM		PPARγ, EC₅₀: 137.4 nM
Methyl oleanonate			PPARγ			99.81%
Azemiglitazone potassium			PPAR-γ, IC₅₀: 18.25 μM			99.53%
F44-A13	PPARα	PPARβ
FK614			PPAR-γ			99.97%
Fenofibrate (Standard)	PPARα					99.91%
Netoglitazone	PPARα		PPARγ			99.88%
ST247		PPARβ/δ				99.88%
Lobeglitazone sulfate	PPARα, EC₅₀: 546.3 nM		PPARγ, EC₅₀: 137.4 nM			99.63%
Fenofibric acid (Standard)	PPARα	PPARδ	PPARγ			99.16%
25-Hydroxytachysterol3			PPARγ			98.89%
SR 11023			PPARγ, IC₅₀: 108 nM			99.55%
PPARγ phosphorylation inhibitor 1			PPARγ, IC₅₀: 24 nM			99.81%
RG-12525			PPARγ, IC₅₀: 60 nM			98.31%
Edaglitazone	PPARα, EC₅₀: 1053 nM		PPARγ, EC₅₀: 35.6 nM			99.58%
H-Trp-Glu-OH			PPARγ, Kd: 8 μM			99.95%
1-O-Hexadecylglycerol			PPAR-γ			≥98.0%
BAY-5094			PPAR-γ			98.04%
MA-0204		PPARδ, EC₅₀: 0.4 nM (in human) PPARδ, EC₅₀: 7.9 nM (in mouse) PPARδ, EC₅₀: 10 nM (in rat)				99.31%
SDPC			PPARγ
13-Oxo-9E,11E-octadecadienoic acid	PPARα
Clofibrate (Standard)	PPARα		PPARγ			98.09%
Angeloylgomisin H			PPAR-γ			99.79%
Gemfibrozil (Standard)	PPAR-α					99.90%
GSK376501A			PPARγ			99.06%
10-Nitrolinoleic acid			PPARγ, IC₅₀: 0.22 μM
Arhalofenate			PPAR-γ
PPAR agonist 1	PPARα		PPARγ			98.39%
(±)4-HDHA			PPARγ			99.05%
Rosiglitazone potassium			PPARγ, Kd: 40 nM PPARγ, EC₅₀: 60 nM
Pparδ agonist 5					PPARδ, EC₅₀: 0.335 μM
Pioglitazone potassium	hPPARα, EC₅₀: 100 μM mouse PPARα, EC₅₀: 100 μM	hPPARδ, EC₅₀: 43 μM	mouse PPARγ, EC₅₀: 0.99 μM h-PPARγ, EC₅₀: 0.93 μM
Seladelpar Lysine dihydrate					PPARδ, EC₅₀: 2 nM	≥98.0%
PPARα/δ agonist 1	PPARα, EC₅₀: 7 nM		PPARγ, EC₅₀: 1316.1 nM		PPARδ, EC₅₀: 8.4 nM
PPARγ/δ modulator 1			PPARγ, Ki: 5.31 μM		PPARδ, Ki: 14.4 nM
MBX-102 acid			PPARγ
Icariin (Standard)	PPARα
PPARα agonist 1	hPPARα
PPARδ agonist 11	hPPARα, EC₅₀: 8 μM	hPPARδ, EC₅₀: 0.02 μM
PPARγ modulator-2			PPARγ, IC₅₀: 41 nM
Glabridin (Standard)			PPARγ
Cevoglitazar	PPARα		PPARγ
PPARγ modulator-1			PPAR-γ
Ginsenoside Rh1 (Standard)			PPAR-γ
PPARγ agonist 8			PPARγ
PPARγ/δ modulator 2			PPARγ		PPARδ
PPARγ-IN-3			PPARγ
PPARα/γ agonist 4	PPARα		PPAR-γ
PPAR agonist 5	PPARα, EC₅₀: 3.20 μM	PPARβ/δ, EC₅₀: 1.51 μM	PPARγ, EC₅₀: 1.92 μM
Avicularin (Standard)			PPARγ
PPARα/δ agonist 3	PPARα, IC₅₀: 5.6 nM		PPARγ, IC₅₀: 1278 nM		PPARδ, IC₅₀: 3.4 nM
4,5-DiHDPA lactone			PPARγ
L-783483					PPARδ
Rac-Pemafibrate	h-PPARα, EC₅₀: 1 nM	h-PPARδ, EC₅₀: 1.7 μM
Mesalamine impurity P				PPAR
SKLB102			PPAR-γ
Apo-12'-lycopenal			PPAR-γ
PPARγ/GR modulator 1			PPARγ, Ki: 3.3 μM
Romazarit	PPARα
Darglitazone Sodium			PPAR-γ
DSO-5a			PPARγ
PPARγ-IN-5			PPARγ
9(10)-Nitrooleate	PPARα	PPARβ/δ	PPARγ
CAY10410			PPARγ
YGT-31			PPARγ, IC₅₀: 1.72 μM PPARγ, Ki: 0.62 μM
Tibesaikosaponin V			PPARγ
Caulophyllogenin			PPARγ, EC₅₀: 12.6 μM
BMS711939	hPPARα, IC₅₀: 4 nM		hPPARγ, IC₅₀: 4.5 μM
PPARα/γ agonist 2	PPARα, EC₅₀: 0.95 μM		PPARγ, EC₅₀: 0.91 μM
Eupatilin (Standard)	PPARα
DS-6930			PPARγ, EC₅₀: 41 nM
Ciprofibrate impurity A	PPARα
ZLY06			PPARγ, IC₅₀: 237 nM		PPARδ, IC₅₀: 341 nM
MRL-24			PPARγ
PPARδ agonist 10					PPARδ, EC₅₀: 0.053 μM (hPPARδ) PPARδ, EC₅₀: 0.30 μM (mPPARδ)
PPARγ agonist 16			PPAR-γ, IC₅₀: 1790 nM
PPARα/δ agonist 2	PPARα, EC₅₀: 3255 nM	PPARβ/δ, EC₅₀: 1475 nM
SR2595			PPARγ, IC₅₀: 30 nM
PPAR agonist 4	PPARα, EC₅₀: 0.7 μM		PPARγ, EC₅₀: 1.8 μM		PPARδ, EC₅₀: 0.7 μM
Amezalpat	PPARα, IC₅₀: 58 nM
PPARγ agonist 2			PPARγ
Cinoxate			PPARγ, Ki: 18 μM
GW1929 hydrochloride			hPPARγ, pKi: 8.84
Chiglitazar sodium	PPARα, EC₅₀: 1.8 μM	PPAR-δ, EC₅₀: 1.7 μM	PPAR-γ, EC₅₀: 0.08 μM
E0924G		PPARδ, EC₅₀: 2.82 μM
Gancaonin L			PPAR-γ
GW7845			PPARγ
ZINC17167211	PPAR-α, EC₅₀: 0.16 nM
T2384			PPARγ
Rosiglitazone sodium			PPARγ1, EC₅₀: 30 nM PPARγ2, EC₅₀: 100 nM
N-Octadecyl-N'-propyl-sulfamide	PPARα
TZD18	hPPARα, IC₅₀: 0.028 μM		hPPARγ, IC₅₀: 0.057 μM		PPARδ, IC₅₀: >10 μM
PT-S58		PPARβ/δ, IC₅₀: 98 nM
Imiglitazar	PPARα, EC₅₀: 67 nM		PPARγ1, EC₅₀: 31 nM
Prostaglandin A3			PPAR-γ, Ki: 188 μM
NS-220	PPARα, EC₅₀: 19 nM		PPARγ, EC₅₀: 9.6 μM		PPARδ, EC₅₀: >1 mM
Inolitazone			PPARγ
PPARα agonist 2	PPARα, EC₅₀: 37 nM
GW 2433	PPARα				PPARδ
AZD4619	PPARα
Sitofibrate	PPAR-α
SR-1903			PPARγ, IC₅₀: 209 nM
CLX-0921			PPARγ, IC₅₀: 1.54 μM
AVE-8134	PPARα, EC₅₀: 100 nM (Human PPARα)
GW409544	PPARα, EC₅₀: 2.3 nM		PPAR-γ, EC₅₀: 0.28 nM
17-Oxo-7(Z),10(Z),13(Z),15(E),19(Z)-docosapentaenoic acid			PPARγ
Prostaglandin B3			PPARγ
Elaidyl-sulfamide	PPARα
Fonadelpar		PPARδ
KD-3010		PPARδ
LJ570	PPARα, EC₅₀: 1.05 μM		PPARγ, EC₅₀: 0.12 μM
Pparδ agonist 2		PPARδ
Pparδ agonist 1		PPARδ, EC₅₀: 5.06 nM
PPARα-MO-1	PPARα

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。	站点地图隐私声明
沪ICP备15051369号-4 上海工商沪公网安备31011502019417 沪(浦)应急管危经许[2021]201709(QFYS) 营业执照（三证合一）
Copyright © 2013-2025 MedChemExpress. All Rights Reserved.

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。

站点地图隐私声明

沪ICP备15051369号-4